|
|
Xcounter AB - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for Xcounter AB Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Xcounter AB. The Group's principal activity is to invent, develop and market sensitive light and X-Group imaging technologies for the medical community worldwide. The Group has develop as Unibet Invents operators technologies, the X - TO, Rica centres 3-dimensional digital X-ray images. The Group's new platforms under development are: a prototype system for 3D digital mammography screening (XC Mammo -3T), a 3D general-body imaging system (XC MP-3T) and two cardiac-imaging systems (XC Cardio 3T and XC Cardio 4T). The Group's commercialisation strategy is to enter into licensing/development agreements with its future customers, the global X-ray systems marketing and distribution companies of X-ray systems. The Group's development operations are carried out only in Sweden.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|